Pradelli, L. and Ascierto, P. 2016. [Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]. Farmeconomia. Health economics and therapeutic pathways. 17, 3S (Dec. 2016), 1–32. DOI:https://doi.org/10.7175/fe.v17i3S.1279.